Table 1: Baseline Characteristics of the 90 study patients.
| Age, years | 59.93 | (± 14.7) |
| Male sex | 63 | -70% |
| Weight, kg | 82.35 | (± 16.5) |
| APACHE II | 17.77 | (± 8.7) |
| SOFA | 10 | (± 7) |
| Diagnosis at ICU admission | ||
| •Multiple Organ Disfunction Syndrome | 67 | (74.4%) |
| • Post Cardiac Arrest | 10 | (11.1%) |
| • Surgery | 7 | (7.8%) |
| • Others | 6 | (6.7%) |
| Acute kidney injury etiologies | ||
| • Septic | 72 | -80% |
| • Ischemic | 12 | (13.3%) |
| • Others | 6 | (6.7%) |
| Life support | ||
| • Mechanical ventilation | 74 | (82.2%) |
| • Vasoactive drugs | 81 | -90% |
| Analytical parameters | ||
| • Creatinine. mg/dl | 3.26 | (± 16.5) |
| • Urea, mg/dl | 96 | (± 52.6) |
| Coagulation | ||
| • Platelets, 103/mm3 | 220 | (± 165) |
| • Activated partial thromboplastin time, ratio | 1.1 | (± 0.3) |
| Liver function | ||
| • Bilirrubine, mg/dl | 1.2 | (± 0.6) |
| • Aspartate Transaminase, U/L | 22 | (± 8) |
| • Alanine Transaminase, U/L | 20 | (± 6) |
| • Gamma-Glutamyl Transferase, U/L | 28 | (± 12) |
| • Urine output 12 hours before CRRT, ml | 198 | (± 155) |
| • Initial CRRT dose prescribed, ml/kg/h | 32 | (± 11.5) |
| • ICU stay, days | 17 | (7-28) |
| • CRRT length, days | 6.5 | (4-17.25) |
Data presented as number of patients (%), mean value (± SD) or median (IQR).